re: Ann: Human Clinical Study for an Oral Tre... Best part is BNE is not trying to prove up a new drug with its CaPTHymone
Its simply trying to offer a new delivery system for the drug Forteo which is an injection and has annual sales of $1.2Billion US
So if you are already part of the group that spends $1.2Billion on that injection are you not going to switch to a tablet if it does the same thing?
EV $3m?
Ann: Human Clinical Study for an Oral Treatment f, page-4
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287187 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1920397 | 33 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |